Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study

被引：1

作者：

Torres, Tiago ^{[1
,2
]}

Yeung, Jensen ^{[3
,4
,5
,6
]}

Prajapati, Vimal ^{[7
,8
,9
,10
]}

Ribero, Simone ^{[11
]}

Balato, Anna ^{[12
]}

Valerio Marzano, Angelo ^{[13
,14
]}

Cruz, Maria Joao ^{[15
,16
]}

Paiva Lopes, Maria Joao ^{[17
]}

Lazaridou, Elizabeth ^{[18
]}

Carrascosa, Jose-Manuel ^{[19
]}

Alvarenga, Jose Miguel ^{[1
]}

Farinha, Pedro ^{[17
]}

Duarte, Bruno ^{[17
]}

Sood, Siddhartha ^{[20
]}

Rankin, Brian D. ^{[7
]}

Ortoncelli, Michela ^{[11
]}

Caccavale, Stefano ^{[12
]}

Ferrucci, Silvia Mariel ^{[13
]}

Rosa, Gilberto Pires ^{[15
,16
]}

Daponte, Athina Ioanna ^{[18
]}

Silvi, Gianmarco ^{[21
]}

Peris, Ketty ^{[22
,23
]}

Gori, Niccolo ^{[22
,23
]}

Herranz, Pedro ^{[19
]}

Prignano, Francesca ^{[21
]}

Kolios, Antonio ^{[24
,25
]}

Rompoti, Natalia ^{[26
,27
]}

Gkalpakiotis, Spyridon ^{[26
,27
]}

Chiricozzi, Andrea ^{[22
,23
]}

机构：

[1] Ctr Hosp Univ Santo Antonio Porto, Dept Dermatol, Porto, Portugal

[2] Univ Porto, Inst Ciencias Biomed Abel Salazar, Porto, Portugal

[3] Univ Toronto, Dept Med, Div Dermatol, Toronto, ON, Canada

[4] Womens Coll Hosp, Dept Med, Div Dermatol, Toronto, ON, Canada

[5] Sunnybrook Hlth Sci Ctr, Dept Med, Div Dermatol, Toronto, ON, Canada

[6] Prob Med Res, Toronto, ON, Canada

[7] Univ Calgary, Dept Med, Div Dermatol, Calgary, AB, Canada

[8] Dermatol Res Inst, Calgary, AB, Canada

[9] Skin Hlth & Wellness Ctr, Calgary, AB, Canada

[10] Prob Med Res, Calgary, AB, Canada

[11] Univ Turin, Dept Med Sci, Dermatol Clin, Turin, Italy

[12] Univ Campania Luigi Vanvitelli, Unit Dermatol, Naples, Italy

[13] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dermatol Unit, Milan, Italy

[14] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[15] Unidade Local Saude Sao Joao, Dept Dermatol, Porto, Portugal

[16] Univ Porto, Fac Med, Porto, Portugal

[17] Ctr Hosp Univ Lisboa Cent, Neurol Dept, Lisbon, Portugal

[18] Aristotle Univ Thessaloniki, Dept Dermatol & Venereol, Sch Med, Thessaloniki, Greece

[19] Hosp Univ Germans Trias i Pujol, Barcelona, Spain

[20] Univ Toronto, Temerty Fac Med, Toronto, ON, Canada

[21] Univ Florence, Dept Hlth Sci, Dermatol Sect, Florence, Italy

[22] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Dermatol, Rome, Italy

[23] Fdn Policlin Univ A Gemelli IRCCS, Dipartimento Sci Med & Chirurg, UOC Dermatol, Rome, Italy

[24] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA

[25] Univ Hosp Bern, Dept Dermatol, Inselspital, Bern, Switzerland

[26] Charles Univ Prague, Univ Hosp Kralovske Vinohrady, Fac Med 3, Stare Mesto, Czech Republic

[27] Charles Univ Prague, Fac Med 3, Stare Mesto, Czech Republic

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2025年

关键词：

D O I：

10.1111/jdv.20581

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

引用

页数：6

共 50 条

[1] Upadacitinib for Refractory Paediatric Atopic Dermatitis: A Real-World Study on Effectiveness and Safety in Dupilumab Nonresponders
Zhao, Mutong
Zhuang, Yi
Liang, Yuan
Ma, Lin
Shen, Chunping
CLINICAL AND EXPERIMENTAL ALLERGY, 2024, 54 (09): : 694 - 696
[2] Effectiveness of Tralokinumab in Different Phenotypes of Atopic Dermatitis: A Real-World Study
Tolino, Ersilia
Ambrosio, Luca
Bernardini, Nicoletta
Proietti, Ilaria
Skroza, Nevena
Potenza, Concetta
DERMATOLOGY AND THERAPY, 2025, 15 (02) : 337 - 350
[3] Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice
Hagino, Teppei
Saeki, Hidehisa
Fujimoto, Eita
Kanda, Naoko
ANNALS OF DERMATOLOGY, 2025, 37 (02) : 86 - 95
[4] Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study
Zhou, Bingjing
Peng, Cong
Li, Liqiao
Liu, Runqiu
Zhu, Lei
Chen, Xiang
Li, Jie
FRONTIERS IN MEDICINE, 2022, 9
[5] Effectiveness of dupilumab in tralokinumab-resistant patients with atopic dermatitis: A real-world experience from two referral centres
Tavoletti, Gianluca
Chiei-Gallo, Alessandra
Gargiulo, Luigi
Avallone, Gianluca
Ibba, Luciano
Barei, Francesca
Calzari, Paolo
Narcisi, Alessandra
Marzano, Angelo V.
Ferrucci, Silvia M.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (02) : e163 - e165
[6] Real-world effectiveness and safety of upadacitinib for the treatment of atopic dermatitis in adult patients switched from dupilumab: A multicenter retrospective study
Georgakopoulos, Jorge R.
Sheka, Dropen
Rankin, Brian
Maliyar, Khalad
Rimke, Alexander
Prajapati, Vimal H.
Yeung, Jensen
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (06) : 1308 - 1311
[7] Effectiveness of abrocitinib for the treatment of moderate-to-severe atopic dermatitis in patients switched from dupilumab and/or tralokinumab: A real-world retrospective study
Keow, Samantha
Abu-Hilal, Mohannad
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (04) : 734 - 735
[8] Efficacy of tralokinumab after failure with upadacitinib and dupilumab in a patient affected by atopic dermatitis
Mastorino, L.
Gelato, F.
Quaglino, P.
Ortoncelli, M.
Ribero, S.
JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
[9] Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Barei, Francesca
Calzari, Paolo
Valtellini, Luca
Chiei Gallo, Alessandra
Perego, Gabriele
Tavecchio, Simona
Zussino, Martina
Marzano, Angelo V.
Ferrucci, Silvia
JOURNAL OF DERMATOLOGICAL TREATMENT, 2024, 35 (01)
[10] Real-world use of dupilumab for 53 patients with atopic dermatitis in Japan
Matsutani, Masako
Imai, Yasutomo
Inoue, Yukako
Hosotani, Yuka
Kusakabe, Minori
Natsuaki, Masaru
Yamanishi, Kiyofumi
JOURNAL OF CUTANEOUS IMMUNOLOGY AND ALLERGY, 2020, 3 (02) : 35 - 36

← 1 2 3 4 5 →